NEOPULSE Trademark Information

Trademark by OncoSec Medical Incorporated

medical devices to treat disease by using electroporation to deliver cytotoxic agents directly resulting in local ablation of disease

therapy to treat disease by using electroporation to deliver cytotoxic agents directly resulting in local ablation of disease

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (010)
Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
Class (044)
Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: NEOPULSE
Status/Status Date:
ABANDONED - NO STATEMENT OF USE FILED
2/29/2016
Serial Number: 85669713
Filing Date: 7/5/2012
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: medical devices to treat disease by using electroporation to deliver cytotoxic agents directly resulting in local ablation of disease
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 12/4/2012
Last Applicant/Owner:
OncoSec Medical Incorporated
San Diego, CA 92121
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Morgan, Lewis & Bockius LLP
One Market, Spear Street Tower
San Francisco CA 94105
Current Status:
ABANDONED - NO STATEMENT OF USE FILED
2/29/2016
Correspondent Search:
Carla B. Oakley is a correspondent of NEOPULSE trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on